The NHGRI said it expects to fund between three and five research centers, as well as one coordinating center, over a five year period.
Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.
Researchers identified a new type 2 diabetes-associated site involving the ZRANB3 gene, which may have a role in regulating pancreatic beta cells.
The two-year award will fund development and commercialization of the firm's HLS-Catch platform and follows a previous grant of $191,535.
The initiative, funded in partnership with NHGRI and Color, will mentor 40 trainees through a competitive process and host programs to encourage diversity.
The Telomere-to-Telomere consortium has already generated a gapless assembly of the human X chromosome and aims to complete all chromosomes over the next two years or so.
The Human Genome Reference Program aims to build a human genome reference that better accounts for genetic diversity than the existing reference.
A new analysis pointed to a rise in over-generalized or incorrect bacterial identification by k-mer lowest common ancestor methods as the database has grown.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.